Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Total Revenue

Aerie Pharmaceuticals Total Revenue Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Total Revenue from 2018 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Aerie Pharmaceuticals Total Revenue for the quarter ending June 06, 2020 was $18m a -2.83% decrease of -1m year over year
  • Aerie Pharmaceuticals Total Revenue for the last 12 months ending June 06, 2020 was $82m a 26.83% increase of 22m year over year
  • Aerie Pharmaceuticals Annual Total Revenue for 2019 was $70m a 65.40% increase of 46m from 2018
  • Aerie Pharmaceuticals Annual Total Revenue for 2018 was $24m
Other Income Statement Metrics:
  • Aerie Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-51m a 21.13% decrease of -11m year over year
  • Aerie Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-51m a 20.91% decrease of -11m year over year
View Chart On Koyfin

Quarterly AERI Total Revenue Data

06/2020$18m
03/2020$20m
12/2019$25m
09/2019$19m
06/2019$16m
03/2019$11m
12/2018$14m
09/2018$7m
06/2018$2m

Annual AERI Total Revenue Data

2019$70m
2018$24m